SCHEMBL20165909

SCHEMBL20165909

CN(C)NC(=O)c1ccnc(N2CCC(C(=O)N3N=CCC3c3ccccc3)CC2)n1

nearest known ligand 0.68

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 20/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20165907 1.00 RIPK1 (0.68) RIPK1
SCHEMBL20165730 0.88 RIPK1 (0.71) RIPK1
SCHEMBL20165731 0.88 RIPK1 (0.71) RIPK1
SCHEMBL20166588 0.88 RIPK1 (0.70) RIPK1
SCHEMBL20166587 0.88 RIPK1 (0.70) RIPK1
SCHEMBL20168815 0.87 RIPK1 (0.78) RIPK1
SCHEMBL20168812 0.87 RIPK1 (0.78) RIPK1
SCHEMBL20182745 0.86 RIPK1 (0.77) RIPK1
SCHEMBL21546090 0.86 RIPK1 (0.77) RIPK1
SCHEMBL20165694 0.86 RIPK1 (0.68) RIPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3541813-A1 HETEROCYCLIC AMIDES AS KINASE INHIBITORS GlaxoSmithKline Intellectual Property Development Limited (GB) 2019-09-25 EP disclosed
WO-2018154520-A1 HETEROCYCLIC AMIDES AS KINASE INHIBITORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2018-08-30 WO disclosed
WO-2018092089-A1 HETEROCYCLIC AMIDES AS KINASE INHIBITORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2018-05-24 WO disclosed